17 research outputs found
DNA hypermethylation of the serotonin receptor type-2A gene is associated with a worse response to a weight loss intervention in subjects with metabolic syndrome
Understanding the regulation of gene activities depending on DNA methylation has been the subject of much recent study. However, although polymorphisms of the HTR2A gene have been associated with both obesity and psychiatric disorders, the role of HTR2A gene methylation in these illnesses remains uncertain. The aim of this study was to evaluate the association of HTR2A gene promoter methylation levels in white blood cells (WBC) with obesity traits and depressive symptoms in individuals with metabolic syndrome (MetS) enrolled in a behavioural weight loss programme. Analyses were based on 41 volunteers (mean age 49 ± 1 year) recruited within the RESMENA study. Depressive symptoms (as determined using the Beck Depression Inventory), anthropometric and biochemical measurements were analysed at the beginning and after six months of weight loss treatment. At baseline, DNA from WBC was isolated and cytosine methylation in the HTR2A gene promoter was quantified by a microarray approach. In the whole-study sample, a positive association of HTR2A gene methylation with waist circumference and insulin levels was detected at baseline. Obesity measures significantly improved after six months of dietary treatment, where a lower mean HTR2A gene methylation at baseline was associated with major reductions in body weight, BMI and fat mass after the treatment. Moreover, mean HTR2A gene methylation at baseline significantly predicted the decrease in depressive symptoms after the weight loss treatment. In conclusion, this study provides newer evidence that hypermethylation of the HTR2A gene in WBC at baseline is significantly associated with a worse response to a weight-loss intervention and with a lower decrease in depressive symptoms after the dietary treatment in subjects with MetS
Dietary factors, epigenetic modifications and obesity outcomes: Progresses and perspectives
Nutritional factors play a life-long role in human health. Indeed, there is growing evidence that one of the mechanisms by which nutrients and bioactive compounds affect metabolic traits is epigenetics. Complex interactions among food components and histone modifications, DNA methylation, non-coding RNA expression and chromatin remodeling factors lead to a dynamic regulation of gene expression that controls the cellular phenotype. Although perinatal period is the time of highest phenotypic plasticity, contributing largely to developmental programming, also during adulthood there is evidence about a nutritional influence on epigenetic regulation. Similarly to type 2 diabetes, hypertension, atherosclerosis and other metabolic disorders, obesity predisposition and weight loss outcomes have been repeatedly associated to changes in epigenetic patterns. Different non-nutritional risk factors that usually accompany obesity seem also to be involved in these epigenetic modifications, especially hyperglycemia, inflammation, hypoxia and oxidative stress. There are currently three major objectives in epigenetic research in relation to obesity: to search for epigenetic biomarkers to predict future health problems or detect the individuals at most risk, to understand the obesity-related environmental factors that could modulate gene expression by affecting epigenetic mechanisms, and to study novel therapeutic strategies based on nutritional or pharmacological agents that can modify epigenetic marks. At this level, the major tasks are: development of robust epigenetic biomarkers of weight regulation, description of those epigenetic marks more susceptible to be modified by dietary exposures, identification of the active ingredients (and the doses) that alter the epigenome, assessment of the real importance of other obesity-related factors on epigenetic regulation, determination of the period of life in which best results are obtained, and understanding the importance of the inheritance of these epigenetic marks
Techniques of DNA methylation analysis with nutritional applications
Epigenetic mechanisms are likely to play an important role in the regulation of metabolism
and body weight through gene-nutrient interactions. This review focuses on methods for
analyzing one of the most important epigenetic mechanisms, DNA methylation, from single
nucleotide to global measurement depending on the study goal and scope. In addition, this
study highlights the major principles and methods for DNA methylation analysis with emphasis
on nutritional applications. Recent developments concerning epigenetic technologies are
showing promising results of DNA methylation levels at a single-base resolution and provide
the ability to differentiate between 5-methylcytosine and other nucleotide modifications such
as 5-hydroxymethylcytosine. A large number of methods can be used for the analysis of DNA
methylation such as pyrosequencing TM , primer extension or real-time PCR methods, and genome-wide DNA methylation profile from microarray or sequencing-based methods. Researchers
should conduct a preliminary analysis focused on the type of validation and information
provided by each technique in order to select the best method fitting for their
nutritional research interests
Differential DNA Methylation in relation to age and health risks of obesity
The aim of this study was to evaluate whether genome-wide levels of DNA methylation are associated with age and the health risks of obesity (HRO); defined according to BMI categories as "Low HRO" (overweight and class 1 obesity) versus "High HRO" (class 2 and class 3 obesity). Anthropometric measurements were assessed in a subsample of 48 volunteers from the Metabolic Syndrome Reduction in Navarra (RESMENA) study and 24 women from another independent study, Effects of Lipoic Acid and Eicosapentaenoic Acid in Human Obesity (OBEPALIP study). In the pooled population; the methylation levels of 55 CpG sites were significantly associated with age after Benjamini-Hochberg correction. In addition, DNA methylation of three CpG sites located in ELOVL2; HOXC4 and PI4KB were further negatively associated with their mRNA levels. Although no differentially methylated CpG sites were identified in relation to HRO after multiple testing correction; several nominally significant CpG sites were identified in genes related to insulin signaling; energy and lipid metabolism. Moreover, statistically significant associations between BMI or mRNA levels and two HRO-related CpG sites located in GPR133 and ITGB5 are reported. As a conclusion, these findings from two Spanish cohorts add knowledge about the important role of DNA methylation in the age-related regulation of gene expression. In addition; a relevant influence of age on DNA methylation in white blood cells was found, as well as, on a trend level, novel associations between DNA methylation and obesity
Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet
The arylesterase (ARE) activity linked to the paraoxonase-1 (PON1) gene is known to protect
lipoproteins from oxidation and provide defense against metabolic syndrome (MetS) and cardiovascular
diseases. The epigenetic regulation of enzymatic activities is gaining importance
nowadays. This research aimed to assess the potential relationships between the ARE activity
with the methylation levels of the PON1 gene transcriptional regulatory region, anthropometrics,
biochemical markers and antioxidant dietary components. Forty-seven subjects
(47 ± 10 y.o; BMI 36.2 ± 3.8 kg/m2; 46.8 % female) with MetS features, who followed a sixmonth
energy-restricted dietary weight-loss intervention, were included in this study
(www.clinicaltrials.gov; NCT01087086). Anthropometric, biochemical, enzymatic and dietary
data were assessed using validated procedures. PON1 transcriptional regulatory region
methylation was analyzed by a microarray technical approach. Volunteers reduced ARE activity
in parallel with body weight (p = 0.005), BMI (p = 0.006), total fat mass (p = 0.020), diastolic
blood pressure (p = 0.018), mean blood pressure (p = 0.022) and triglycerides
(p = 0.014). Methylation levels of some CpG sites of the PON1 gene correlated negatively
with ARE activity (p < 0.05). Interestingly, dietary vitamin C (p = 0.001), tocopherols
(p = 0.009) and lycopene (p = 0.038) were positively associated with ARE activity and
showed an inverse correlation (p = 0.004, p = 0.029 and p = 0.021, respectively) with the
methylation of some selected CpG sites of the PON1 gene. In conclusion, ARE activity decreased
in parallel with MetS-related markers associated to the energy restriction, while dietary
antioxidants might enhance the ARE activity by lowering the PON1 gene methylation in
patients with MetS features
DNA methylation in genes of longevityâregulating pathways: association with obesity and metabolic complications
Aging is the main risk factor for most chronic diseases. Epigenetic mechanisms, such as DNA methylation
(DNAm) plays a pivotal role in the regulation of physiological responses that can vary along lifespan. The aim of
this research was to analyze the association between leukocyte DNAm in genes involved in longevity and the
occurrence of obesity and related metabolic alterations in an adult population. Subjects from the MENA cohort
(n=474) were categorized according to age () and the presence of metabolic alterations: increased
waist circumference, hypercholesterolemia, insulin resistance, and metabolic syndrome. The methylation levels
of 58 CpG sites located at genes involved in longevityâregulating pathways were strongly correlated (FDRâ
adjusted< 0.0001) with BMI. Fifteen of them were differentially methylated (p<0.05) between younger and
older subjects that exhibited at least one metabolic alteration. Six of these CpG sites, located at MTOR
(cg08862778), ULK1 (cg07199894), ADCY6 (cg11658986), IGF1R (cg01284192), CREB5 (cg11301281), and RELA
(cg08128650), were common to the metabolic traits, and CREB5, RELA, and ULK1 were statistically associated
with age. In summary, leukocyte DNAm levels of several CpG sites located at genes involved in longevityâ
regulating pathways were associated with obesity and metabolic syndrome traits, suggesting a role of DNAm in
agingârelated metabolic alterations
Epigenome-wide association study in peripheral white blood cells involving insulin resistance
Insulin resistance (IR) is a hallmark of type 2 diabetes, metabolic syndrome and cardiometabolic risk. An epigenetic phenomena such as DNA methylation might be involved in the onset and development of systemic IR. The aim of this study was to explore the genetic DNA methylation levels in peripheral white blood cells with the objective of identifying epigenetic signatures associated with IR measured by the Homeostatic Model Assessment of IR (HOMA-IR) following an epigenome-wide association study approach. DNA methylation levels were assessed using Infinium Methylation Assay (Illumina), and were associated with HOMA-IR values of participants from the Methyl Epigenome Network Association (MENA) project, finding statistical associations for at least 798 CpGs. A stringent statistical analysis revealed that 478 of them showed a differential methylation pattern between individuals with HOMA-IRââ€â3 and >â3. ROC curves of top four CpGs out of 478 allowed differentiating individuals between both groups (AUCâ0.88). This study demonstrated the association between DNA methylation in some specific CpGs and HOMA-IR values that will help to the understanding and in the development of new strategies for personalized approaches to predict and prevent IR-associated diseases
Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population
Summary: The main objective was to evaluate the association between SNPs and haplotypes of the FABP1-4 genes and type 2 diabetes, as well as its interaction with fat intake, in one general Spanish population. The association was replicated in a second population in which HOMA index was also evaluated.
Methods: 1217 unrelated individuals were selected from a population-based study [Hortega study: 605 women; mean age 54 y; 7.8% with type 2 diabetes]. The replication population included 805 subjects from Segovia, a neighboring region of Spain (446 females; mean age 52 y; 10.3% with type 2 diabetes). DM2 mellitus was defined in a similar way in both studies. Fifteen SNPs previously associated with metabolic traits or with potential influence in the gene expression within the FABP1-
4 genes were genotyped with SNPlex and tested. Age, sex and BMI were used as covariates in the logistic regression model.
Results:One polymorphism (rs2197076) and two haplotypes of the FABP-1 showed a strong association with the risk of DM2
in the original population. This association was further confirmed in the second population as well as in the pooled sample.
None of the other analyzed variants in FABP2, FABP3 and FABP4 genes were associated. There was not a formal interaction
between rs2197076 and fat intake. A significant association between the rs2197076 and the haplotypes of the FABP1 and
HOMA-IR was also present in the replication population.
Conclusions: The study supports the role of common variants of the FABP-1 gene in the development of type 2 diabetes in Caucasians
The nutrigenetic influence of the interaction between dietary vitamin E and TXN and COMT gene polymorphisms on waist circumference: a case control study
Background: Abdominal obesity (AO) is a common modifiable risk factor for certain non-communicable diseases
associated with enhanced oxidative stress (OS). The objective of this work was to investigate whether the interaction
between antioxidant vitamin intake and OS-related polymorphisms modulates gene-associated anthropometry in a
Spanish population.
Methods: A total of 246 subjects with AO, and 492 age and gender matched non-AO subjects were included in the
study. Anthropometric, biochemical, and OS parameters, and antioxidant dietary intake data were assessed using validated
procedures. DNA from white blood cells was isolated and the genotype of seven polymorphisms from genes
involved in OS (pro-oxidant and antioxidant) were analyzed using the SNPlex system. The effects of the c.-793T > C
polymorphism on promoter activity and thus thioredoxin (TXN) activity were examined using reporter assays.
Results: The AO group had higher 8-Oxo-2âČ-deoxyguanosine levels and took in less vitamin A and vitamin E compared
to the non-AO group. Logistic regression analysis revealed that the rs2301241 polymorphism in TXN and
rs740603 in catechol-O-methyltransferase (COMT) were associated with waist circumference (WC) and AO. Moreover,
these polymorphisms were more strongly associated with variations in WC in subjects with low vitamin E intakes. A
promoter assay revealed that the T to C conversion at c.-793 (rs2301241) induced a more than two fold increase in
reporter gene expression.
Conclusions: WC is associated both with dietary vitamin E intake and genetic variants of TXN and COMT suggesting
that existence of a complex nutrigenetic pathway that involves regulation of AO
Differential DNA methylation in relation to age and health risks of obesity
The aim of this study was to evaluate whether genome-wide levels of DNA
methylation are associated with age and the health risks of obesity (HRO); defined
according to BMI categories as âLow HROâ (overweight and class 1 obesity) versus
âHigh HROâ (class 2 and class 3 obesity). Anthropometric measurements were assessed in
a subsample of 48 volunteers from the Metabolic Syndrome Reduction in Navarra
(RESMENA) study and 24 women from another independent study, Effects of Lipoic Acid
and Eicosapentaenoic Acid in Human Obesity (OBEPALIP study). In the pooled population;
the methylation levels of 55 CpG sites were significantly associated with age after
Benjamini-Hochberg correction. In addition, DNA methylation of three CpG sites located
in ELOVL2; HOXC4 and PI4KB were further negatively associated with their mRNA
levels. Although no differentially methylated CpG sites were identified in relation to HRO
after multiple testing correction; several nominally significant CpG sites were identified in
genes related to insulin signaling; energy and lipid metabolism. Moreover, statistically
significant associations between BMI or mRNA levels and two HRO-related CpG sites
located in GPR133 and ITGB5 are reported. As a conclusion, these findings from two
Spanish cohorts add knowledge about the important role of DNA methylation in the
age-related regulation of gene expression. In addition; a relevant influence of age on DNA methylation in white blood cells was found, as well as, on a trend level, novel associations
between DNA methylation and obesity